A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma. - Dasyam N; Sharples KJ; Barrow C; Huang Y; Bauer E; Mester B; Wood CE; Authier-Hall A; Dzhelali M; Ostapowicz T; Kumar R; Lowe J; et al. (Cancer immunology, immunotherapy : CII, 2023)